Similarly, a previous study found that selective inhibition of histone deacetylase 2 (HDAC2) causes downregulation of BIRC5 through activation of p53, which is mediated by the downregulation of MDM2 in lung cancer (Seo et al., 2015). This evidence concerns the gene MDM2 and lung carcinoma.